It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Targeting the supportive tumor microenvironment (TME) is an approach of high interest in cancer drug development. However, assessing TME-targeted drug candidates presents a unique set of challenges. We develop a comprehensive screening platform that allows monitoring, quantifying, and ranking drug-induced effects in self-organizing, vascularized tumor spheroids (VTSs). The confrontation of four human-derived cell populations makes it possible to recreate and study complex changes in TME composition and cell-cell interaction. The platform is modular and adaptable for tumor entity or genetic manipulation. Treatment effects are recorded by light sheet fluorescence microscopy and translated by an advanced image analysis routine in processable multi-parametric datasets. The system proved to be robust, with strong interassay reliability. We demonstrate the platform’s utility for evaluating TME-targeted antifibrotic and antiangiogenic drugs side-by-side. The platform’s output enabled the differential evaluation of even closely related drug candidates according to projected therapeutic needs.
Assessing tumour microenvironment-targeted drug candidates remains challenging. Here, the authors develop a comprehensive screening platform that allows for monitoring, quantifying, and ranking drug-induced effects in self-organizing, vascularized tumour spheroids.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Julius-Maximilians-Universität Würzburg, Institute of Anatomy and Cell Biology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
2 Julius-Maximilians-Universität Würzburg, Chair of Molecular Microscopy, Rudolf-Virchow-Center for Integrative and Translational Bioimaging, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
3 Universitätsklinikum Würzburg, Institute of Experimental Biomedicine, Würzburg, Germany (GRID:grid.411760.5) (ISNI:0000 0001 1378 7891)
4 Julius-Maximilians-Universität Würzburg, Institute of Anatomy and Cell Biology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); Max Planck Institute of Heart and Lung Research, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
5 Technische Universität Illmenau, Institut für Medientechnik, Illmenau, Germany (GRID:grid.6553.5) (ISNI:0000 0001 1087 7453)
6 Julius-Maximilians-Universität Würzburg, Institute of Anatomy and Cell Biology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); Julius-Maximilians-Universität Würzburg, Graduate School for Life Sciences, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)